Literature DB >> 16643471

Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.

Nathan Lawrentschuk1, Ian D Davis, Damien M Bolton, Andrew M Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643471     DOI: 10.1111/j.1464-410X.2006.06125.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  7 in total

Review 1.  Functional imaging of renal cell carcinoma.

Authors:  Nathan Lawrentschuk; Ian D Davis; Damien M Bolton; Andrew M Scott
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

2.  Co-existing sarcoidosis confounds the staging of bilateral renal cell carcinoma.

Authors:  Heather Willis; Marta Heilbrun; Christopher Dechet
Journal:  J Radiol Case Rep       Date:  2011-01-01

3.  Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies.

Authors:  Jae-Ho Lee; Heejung Kim; Zhengsheng Yao; Sung-Jin Lee; Lawrence P Szajek; Luigi Grasso; Ira Pastan; Chang H Paik
Journal:  Nucl Med Biol       Date:  2015-07-29       Impact factor: 2.408

Review 4.  Active surveillance of small renal masses.

Authors:  Marc C Smaldone; Anthony T Corcoran; Robert G Uzzo
Journal:  Nat Rev Urol       Date:  2013-04-09       Impact factor: 14.432

5.  Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma.

Authors:  Rozemarie Gilles; Lioe-Fee de Geus-Oei; Peter F A Mulders; Wim J G Oyen
Journal:  World J Urol       Date:  2011-07-08       Impact factor: 4.226

6.  Collecting duct carcinoma of the kidney: Imaging observations of a rare tumor.

Authors:  Yuxiao Hu; Guang-Ming Lu; Kai Li; Long-Jiang Zhang; Hong Zhu
Journal:  Oncol Lett       Date:  2013-12-06       Impact factor: 2.967

7.  Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer.

Authors:  Marc C Smaldone; David Yt Chen; Jian Q Yu; Elizabeth R Plimack
Journal:  Biologics       Date:  2012-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.